Literature DB >> 24745325

Bradycardia related to ribavirin in four pediatric patients with Crimean-Congo hemorrhagic fever.

Hasan Tezer1, Aslınur Ozkaya Parlakay, Belgin Gülhan, Ilker Cetin.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a potentially fatal fever due to infection with the CCHF virus, which belongs to the genus Nairovirus in the Bunyaviridae family and causes severe disease in humans, with reported mortality rates of 15-70% (Centers for Disease Control and Prevention 1983 ). Humans become infected through the bites of ticks, by contact with blood or tissue from viremic livestock, or by contact with a patient with CCHF during the acute phase of infection (Khan et al. 1997 ). Uysal et al. ( 2012 ) reported bradycardia in a patient with CCHF related to ribavirin treatment. We have observed the same side effect in four pediatric patients that also resolved with discontinuation of ribavirin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24745325     DOI: 10.1089/vbz.2012.1294

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  2 in total

Review 1.  Ribavirin for treating Crimean Congo haemorrhagic fever.

Authors:  Samuel Johnson; Nicholas Henschke; Nicola Maayan; Inga Mills; Brian S Buckley; Artemisia Kakourou; Rachel Marshall
Journal:  Cochrane Database Syst Rev       Date:  2018-06-05

2.  Ribavirin use in pediatric patients with Crimean Congo Hemorrhagic Fever: is it really necessary?

Authors:  Hasan Tezer; Aslinur Ozkaya-Parlakay; Belgin Gulhan; Saliha Kanik-Yuksek
Journal:  Braz J Infect Dis       Date:  2016-02-02       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.